Aehr (AEHR) director’s trust sells 30,000 shares, keeps large stake

Rhea-AI Filing Summary

Aehr Test Systems director Rhea J. Posedel, through a trust, sold 30,000 shares of common stock in an open-market transaction at $70.00 per share on April 9, 2026. After this sale, the trust still holds 426,979 shares indirectly, and Posedel also holds 71,163 shares directly. The indirect holdings include shares subject to unvested restricted stock units, indicating a continuing equity stake tied to ongoing service or vesting conditions.

Insights

Equity analyst

Director’s trust sells 30,000 shares while keeping a substantial remaining stake.

Director Rhea J. Posedel executed an open-market sale of 30,000 Aehr Test Systems common shares at $70.00 per share via a trust. This is a straightforward disposition with no derivatives exercised in this filing.

Post-transaction, the trust still holds 426,979 shares indirectly, and Posedel also owns 71,163 shares directly. The filing notes that indirect holdings include unvested restricted stock units, underscoring an ongoing, incentive-based equity position despite the sale.

Given the sizable remaining ownership and absence of derivative activity or other complex structures in this excerpt, the transaction appears as a routine liquidity event by a large existing holder rather than a transformative change in ownership.

Insider Trade Summary

Net Seller: 30,000 shares ($2,100,000)

Net Sell 2 txns

Insider POSEDEL RHEA J

Role Director

Sold 30,000 shs ($2.10M)

Type	Security	Shares	Price	Value
Sale	Common Stock	30,000	$70.00	$2.10M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 426,979 shares (Indirect, By Trust); Common Stock — 71,163 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 30,000 shares Sale price: $70.00 per share Indirect shares after sale: 426,979 shares +1 more

4 metrics

Shares sold 30,000 shares Open-market sale on April 9, 2026

Sale price $70.00 per share Price for 30,000-share open-market sale

Indirect shares after sale 426,979 shares Held indirectly by trust following transaction

Direct shares after sale 71,163 shares Directly held common stock following reported transactions

Key Terms

open-market sale, indirect ownership, restricted stock units, Form 4

4 terms

open-market sale financial

"transaction_action":"open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

indirect ownership financial

""direct_or_indirect":"I","nature_of_ownership":"By Trust""

restricted stock units financial

"includes shares subject to unvested restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POSEDEL RHEA J

(Last) (First) (Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT CALIFORNIA 94539

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)
	Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/09/2026		S		30,000	D	$70	426,979	I	By Trust
Common Stock								71,163(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	04/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AEHR director Rhea J. Posedel report?

Rhea J. Posedel reported an open-market sale of 30,000 Aehr Test Systems common shares at $70.00 per share on April 9, 2026. The sale was executed through a trust classified as indirect ownership in the filing.

How many AEHR shares does Rhea J. Posedel hold after the reported sale?

After the reported sale, a trust associated with Rhea J. Posedel holds 426,979 Aehr Test Systems shares indirectly, and Posedel holds an additional 71,163 shares directly. These positions show she remains a significant shareholder following the 30,000-share disposition.

Was the AEHR insider sale an open-market transaction?

Yes. The filing classifies the transaction as an open-market sale of common stock, coded as an "S" transaction. The shares were sold at $70.00 per share, which is explicitly disclosed as the transaction price in the reported data.

Are any of Rhea J. Posedel’s AEHR holdings subject to vesting conditions?

Yes. A footnote explains that the amount reported in the trust’s indirect holdings includes shares subject to unvested restricted stock units. This indicates that a portion of the equity position is tied to future vesting requirements rather than being fully unrestricted.

How does the AEHR Form 4 distinguish direct and indirect ownership for this insider?

The Form 4 shows indirect ownership of 426,979 shares "By Trust" and direct ownership of 71,163 shares. Indirect holdings are attributed to the trust, while direct holdings are in Posedel’s own name, clarifying how different blocks of stock are controlled.